[1] JANG J,HUR H G,SADOWSKY M J,et al.Environmental Escherichia coli:ecology and public health implications-a review[J].J Appl Microbiol,2017,123(3):570-581. [2] CAO X L,ZHANG Z F,SHEN H,et al.Genotypic characteristics of multidrug-resistant Escherichia coli isolates associated with urinary tract infections[J].APMIS,2014,122(11):1088-1095. [3] ZHANG Y W,WANG Q,YIN Y Y,et al.Epidemiology of carbapenem-resistant Enterobacteriaceae infections:report from the China CRE network[J].Antimicrob Agents Chemother,2018,62(2):e01882-e01817. [4] LOGAN L K,WEINSTEIN R A.The epidemiology of carbapenem-resistant Enterobacteriaceae:the impact and evolution of a global menace[J].J Infect Dis,2017,215(suppl_1):S28-S36. [5] CLSI.M100.Performance standards for antimicrobial susceptibility testing:29th informational supplement[S].Wayne,PA:Clinical and Laboratory Standards Institute,2019. [6] POIREL L,WALSH T R,CUVILLIER V,et al.Multiplex PCR for detection of acquired carbapenemase genes[J].Diagn Microbiol Infect Dis,2011,70(1):119-123. [7] ZHANG R,LIU L Z,ZHOU H W,et al.Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China[J].EBioMedicine,2017,19:98-106. [8] NORDMANN P,POIREL L,Walsh T R,et al.The emerging NDM carbapenemases[J].Trends Microbiol,2011,19(12):588-595. [9] KHANA U,MARYAM L,ZARRILLI R.Structure,Geneti cs and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM):a threat to public health[J].BMC Microbiol,2017,17(1):101. [10] TADA T,TSUCHIYA M,SHIMADA K,et al.Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2,NDM-1,NDM-4,and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam[J].BMC Infect Dis,2017,17(1):467. [11] SCHWEIZER C,BISCHOFF P,BENDER J,et al.Plasmid-Mediated Transmission of KPC-2 Carbapenemasein Enterobacteriaceae in Critically Ill Patients[J].Front Microbiol.2019,2(10):276. [12] SOUZA R C D,DABUL A N G,BORALLI C M D S,et al.Dissemination of blaKPC-2 in an NTEKPC by an IncX5 plasmid[J].Plasmid,2019,106:102446. [13] CARROLL A C,WONG A.Plasmid persistence:costs,benefits,and the plasmid paradox[J].Can J Microbiol,2018,64(5):293-304. [14] MATHERS A J,PEIRANO G,PITOUT J D.Escherichia coli ST131:The quintessential example of an international multiresistant high-risk clone[J].Adv Appl Microbiol,2015,90:109-154. [15] ZENG X C,CHI X L,HO B T,et al.Comparative genome analysis of an extensively drug-resistant isolate of avian sequence type 167 Escherichia coli strain sanji with novel In silico serotype O89b:H9[J].mSystems,2019,4(1):e00242-e00218. [16] GIUFRÈM,ERRICO G,ACCOGLI M,et al.Emergence of NDM-5-producing Escherichia coli sequence type 167 clone in Italy[J].Int J Antimicrob Agents,2018,52(1):76-81. [17] NUKUI Y,AYIBIEKE A,TANIGUCHI M,et al.Whole-genome analysis of EC129,an NDM-5-,CTX-M-14-,OXA-10-and MCR-1-co-producing Escherichia coli ST167 strain isolated from Japan[J].J Glob Antimicrob Resist,2019,18:148-150. [18] GRÖNTHAL T,ÖSTERBLAD M,EKLUND M,et al.Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family,Finland,2015[J].Eur Commun Dis Bull,2018,23(27):1700497. |